Abalone Bio

Private Company

The Future of Antibody Drugs is Function First

Biotechnology Research
Emeryville, CA
11-50 employees
Founded 2017

About Abalone Bio

Abalone Bio is a biotechnology company that leverages engineered biology and machine learning to create target-activating antibodies for challenging diseases. The company provides its AI-powered antibody discovery platform and services to pharmaceutical and biotech partners for their discovery campaigns. Abalone Bio is also developing its own pipeline of antibody therapeutics for indications such as peripheral neuropathy, liver fibrosis, and obesity.

Company Classification

Customer Types
B2B
Business Models
ServicesLicensing
Product & Service Types
Antibody Discovery PlatformTherapeutic Antibody DevelopmentAI-driven Drug Discovery Services

Funding

Total Funding

$1.47M

No. of Funding Rounds

4

Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.

Sign up to Ethos